Sign inGet started

Hohneker John

Insider CIK 1695378 · CRIS Director · HGEN Director · CARM Director · ARAV Director · DMTX Director · EVLO Director · AVBP Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CRIS CURIS INC A Award deriv2026-07-072026-07-096,800$5.29 $36.0K6,800SEC↗
AVBP ArriVent BioPharma, Inc. A Award deriv2026-06-182026-06-2213,562— $013,562SEC↗
AVBP ArriVent BioPharma, Inc. A Award deriv2025-06-182025-06-2015,502— $015,502SEC↗
CRIS CURIS INC A Award deriv2025-05-202025-05-2214,400$3.13 $45.1K14,400SEC↗
CRIS CURIS INC A Award deriv2025-01-282025-01-301,600$3.13 $5.0K1,600SEC↗
CARM Carisma Therapeutics Inc. A Award deriv2024-06-262024-06-2719,350— $019,350SEC↗
CRIS CURIS INC A Award deriv2024-05-212024-05-234,250$11.62 $49.4K4,250SEC↗
AVBP ArriVent BioPharma, Inc. A Award deriv2024-05-162024-05-2029,550— $029,550SEC↗
CARM Carisma Therapeutics Inc. A Award deriv2024-04-012024-04-0138,700— $038,700SEC↗
EVLO Evelo Biosciences, Inc. A Award deriv2023-06-082023-06-1220,000— $020,000SEC↗
CRIS CURIS INC A Award deriv2023-01-232023-01-2485,000— $085,000SEC↗
ARAV Aravive, Inc. A Award deriv2022-09-232022-09-2697,063— $097,063SEC↗
HGEN HUMANIGEN, INC A Award deriv2022-07-272022-07-2963,195— $063,195SEC↗
EVLO Evelo Biosciences, Inc. A Award deriv2022-06-092022-06-1320,000— $020,000SEC↗
CRIS CURIS INC A Award deriv2022-01-312022-01-3185,000— $085,000SEC↗
HGEN HUMANIGEN, INC A Award deriv2021-12-312022-01-043,538$2.84 $10.0K3,538SEC↗
CRIS CURIS INC A Award deriv2021-12-022021-12-0625,000— $025,000SEC↗
HGEN HUMANIGEN, INC A Award deriv2021-10-192021-10-2042,866— $042,866SEC↗
ARAV Aravive, Inc. A Award deriv2021-09-102021-09-1322,812— $022,812SEC↗
ARAV Aravive, Inc. A Award deriv2021-07-012021-07-0215,435— $015,435SEC↗
ARAV Aravive, Inc. A Award deriv2021-07-012021-07-025,245— $05,245SEC↗
EVLO Evelo Biosciences, Inc. A Award deriv2021-01-272021-01-2931,380— $031,380SEC↗
DMTX Dimension Therapeutics, In D To issuer deriv2017-11-072017-11-0738,000— $00SEC↗
DMTX Dimension Therapeutics, In A Award deriv2017-01-182017-01-2038,000— $038,000SEC↗